Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-30
DOI
10.1038/s41574-022-00776-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
- (2022) Antonio Ceriello et al. Cardiovascular Diabetology
- Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association
- (2022) Joshua J. Joseph et al. CIRCULATION
- Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data
- (2022) Dianna J Magliano et al. Lancet Diabetes & Endocrinology
- Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries
- (2022) Anna Norhammar et al. DIABETES OBESITY & METABOLISM
- Underutilization of Guideline-Directed Medical Therapy in Heart Failure
- (2022) Harriette G.C. Van Spall et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
- (2022) Adriaan A. Voors et al. NATURE MEDICINE
- Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations
- (2022) Calvin Ke et al. Nature Reviews Endocrinology
- Effect of a Web-Based Management Guide on Risk Factors in Patients With Type 2 Diabetes and Diabetic Kidney Disease
- (2022) Juliana C. N. Chan et al. JAMA Network Open
- A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer
- (2022) Elaine Chow et al. Pharmaceuticals
- 2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults
- (2022) G.B. John Mancini et al. CANADIAN JOURNAL OF CARDIOLOGY
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of multicomponent integrated care on mortality and hospitalization after acute coronary syndrome: a systematic review and meta-analysis
- (2022) Jia-Xin Hoo et al. European Heart Journal-Quality of Care and Clinical Outcomes
- Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2022) Melanie J. Davies et al. DIABETES CARE
- Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence
- (2022) Peter Rossing et al. KIDNEY INTERNATIONAL
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
- (2022) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1–4
- (2022) Aimin Yang et al. Pharmaceuticals
- Empagliflozin in Patients with Chronic Kidney Disease
- (2022) NEW ENGLAND JOURNAL OF MEDICINE
- Identification of two novel subgroups in patients with diabetes mellitus and their association with clinical outcomes: a two‐step cluster analysis
- (2021) Xiao‐fen Xiong et al. Journal of Diabetes Investigation
- Gaps in Evidence‐Based Therapy Use in Insured Patients in the United States With Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease
- (2021) Adam J. Nelson et al. Journal of the American Heart Association
- The residual cardiorenal risk in type 2 diabetes
- (2021) Dario Giugliano et al. Cardiovascular Diabetology
- Once-Weekly Semaglutide in Adults with Overweight or Obesity
- (2021) John P.H. Wilding et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region
- (2021) Lee-Ling Lim et al. JAMA Network Open
- GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
- (2021) Dario Giugliano et al. Cardiovascular Diabetology
- CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries
- (2021) Ofri Mosenzon et al. Cardiovascular Diabetology
- The legacy effect in diabetes: are there long-term benefits?
- (2021) Rachel Folz et al. DIABETOLOGIA
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
- (2021) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
- (2021) Hertzel C. Gerstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
- (2021) Michael A Nauck et al. Lancet Diabetes & Endocrinology
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- 11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Interpreting global trends in type 2 diabetes complications and mortality
- (2021) Mohammed K. Ali et al. DIABETOLOGIA
- Head‐to‐head comparison of contemporary heart failure risk scores
- (2021) Pau Codina et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
- (2021) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Women’s Participation in Cardiovascular Clinical Trials From 2010 to 2017
- (2020) Xurui Jin et al. CIRCULATION
- Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001–2016: a retrospective cohort study
- (2020) Hongjiang Wu et al. DIABETOLOGIA
- The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation
- (2020) Anastasia Poznyak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trends in diabetes-related complications in Hong Kong, 2001–2016: a retrospective cohort study
- (2020) Hongjiang Wu et al. Cardiovascular Diabetology
- Underweight Increases the Risk of End-Stage Renal Diseases for Type 2 Diabetes in Korean Population: Data From the National Health Insurance Service Health Checkups 2009–2017
- (2020) Yang-Hyun Kim et al. DIABETES CARE
- Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets
- (2020) Jonatan Barrera‐Chimal et al. DIABETES OBESITY & METABOLISM
- Young-onset type 2 diabetes mellitus — implications for morbidity and mortality
- (2020) Dianna J. Magliano et al. Nature Reviews Endocrinology
- SGLT2 Inhibition Mediates Protection from Diabetic Kidney Disease by Promoting Ketone Body-Induced mTORC1 Inhibition
- (2020) Issei Tomita et al. Cell Metabolism
- How May GIP Enhance the Therapeutic Efficacy of GLP-1?
- (2020) Ricardo J. Samms et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Global trend of diabetes mortality attributed to vascular complications, 2000–2016
- (2020) Wei Ling et al. Cardiovascular Diabetology
- International consensus definitions of clinical trial outcomes for kidney failure: 2020
- (2020) Adeera Levin et al. KIDNEY INTERNATIONAL
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
- (2020) Christopher J L Murray et al. LANCET
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
- (2020) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE Program: A retrospective cohort analysis
- (2020) Lee-Ling Lim et al. PLOS MEDICINE
- Risk of Cardiovascular Outcomes in Type 2 Diabetes Patients Following Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-IRA Therapy
- (2020) Chintan V. Dave et al. CIRCULATION
- The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
- (2020) Juliana C N Chan et al. LANCET
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- All‐cause and cardiovascular disease mortality in underweight patients with diabetic nephropathy: BioBank Japan cohort
- (2020) Hiroshi Yokomichi et al. Journal of Diabetes Investigation
- Excess Burden of Mental Illness and Hospitalization in Young-Onset Type 2 Diabetes
- (2019) Calvin Ke et al. ANNALS OF INTERNAL MEDICINE
- Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study
- (2019) Justin B. Echouffo-Tcheugui et al. DIABETES CARE
- Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys
- (2019) Jennifer Manne-Goehler et al. PLOS MEDICINE
- Trends of Nontraumatic Lower Extremity Amputation in End-Stage Renal Disease and Diabetes, United States, 2000–2015
- (2019) Jessica L. Harding et al. DIABETES CARE
- Resurgence in Diabetes-Related Complications
- (2019) Edward W. Gregg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks
- (2019) Naveed Sattar et al. CIRCULATION
- Metformin Use and Clinical Outcomes among Patients with Diabetes with or without Heart Failure or Kidney Dysfunction: Observations from the SAVOR-TIMI 53 Trial
- (2019) Brian A. Bergmark et al. CIRCULATION
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up
- (2019) Peter D. Reaven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of Recovery From Moderate to Severe AKI and the Risk for Future Loss of Kidney Function
- (2019) Edward D. Siew et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake
- (2019) Alice E. Adriaenssens et al. Cell Metabolism
- From Hong Kong Diabetes Register to JADE Program to RAMP-DM for Data-Driven Actions
- (2019) Juliana C.N. Chan et al. DIABETES CARE
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
- (2019) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
- (2019) David R Matthews et al. LANCET
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in incidence of total or type 2 diabetes: systematic review
- (2019) Dianna J Magliano et al. BMJ-British Medical Journal
- Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016
- (2019) Pooyan Kazemian et al. JAMA Internal Medicine
- Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
- (2019) Kausik K Ray et al. Lancet Diabetes & Endocrinology
- Cardiovascular outcomes trials in type 2 diabetes: Time to include young adults
- (2019) Calvin Ke et al. DIABETES OBESITY & METABOLISM
- Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure
- (2019) Francesco Giorgino et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Renal physiology of glucose handling and therapeutic implications
- (2019) David Z Cherney et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Addressing Regional Differences in Diabetes Progression: Global Calibration for Diabetes Simulation Model
- (2019) Hui Shao et al. VALUE IN HEALTH
- The Productivity Burden of Diabetes at a Population Level
- (2018) Dianna J. Magliano et al. DIABETES CARE
- Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis
- (2018) Lee Ling Lim et al. DIABETES CARE
- Economic Costs of Diabetes in the U.S. in 2017
- (2018) DIABETES CARE
- Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants
- (2018) Leo F. Buckley et al. DIABETES OBESITY & METABOLISM
- The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
- (2018) Merlin C. Thomas et al. DIABETOLOGIA
- Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs
- (2018) Mikhail Kosiborod et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
- (2018) Katherine R Tuttle et al. Lancet Diabetes & Endocrinology
- Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
- (2018) Emma Ahlqvist et al. Lancet Diabetes & Endocrinology
- Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2018) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- ACCORDION: Ensuring That We Hear the Music Clearly
- (2018) Muh Geot Wong et al. Clinical Journal of the American Society of Nephrology
- Effect of glycaemic control on cardiovascular disease in individuals with type 2 diabetes with pre-existing cardiovascular disease: A systematic review and meta-analysis
- (2018) Yael Barer et al. DIABETES OBESITY & METABOLISM
- How Representative are the Patients Included in the CV outcome Trials with SGLT2 Inhibitors of a General Type 2 Diabetes Population? A Large European Observational study
- (2018) K.I. Birkeland et al. DIABETES OBESITY & METABOLISM
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
- (2018) Julio Rosenstock et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
- (2017) Marc S Sabatine et al. Lancet Diabetes & Endocrinology
- Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events
- (2017) Kenneth W. Mahaffey et al. CIRCULATION
- Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus
- (2017) Robert P. Giugliano et al. CIRCULATION
- The Cardiovascular Biology of Glucagon-like Peptide-1
- (2016) Daniel J. Drucker Cell Metabolism
- Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
- (2016) Muh Geot Wong et al. DIABETES CARE
- Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes?
- (2016) Christina M. Wyatt et al. KIDNEY INTERNATIONAL
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Beyond bridging the know-do gap: a qualitative study of systemic interaction to foster knowledge exchange in the public health sector in The Netherlands
- (2015) Francine van den Driessen Mareeuw et al. BMC PUBLIC HEALTH
- Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors
- (2015) Julio Rosenstock et al. DIABETES CARE
- Association of Cardiometabolic Multimorbidity With Mortality
- (2015) Emanuele Di Angelantonio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Blood Pressure Lowering in Type 2 Diabetes
- (2015) Connor A. Emdin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
- (2015) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
- (2014) Ele Ferrannini et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort
- (2014) Roseanne O Yeung et al. Lancet Diabetes & Endocrinology
- Glucagon-like peptide-1 (GLP-1) and its split products GLP-1(9-37) and GLP-1(28-37) stabilize atherosclerotic lesions in apoe−/− mice
- (2013) Mathias Burgmaier et al. ATHEROSCLEROSIS
- Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
- (2013) Katherine M. Flegal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
- (2013) B. Finan et al. Science Translational Medicine
- Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST)
- (2012) Alice Pressman et al. Contemporary Clinical Trials
- Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
- (2012) J. Hong et al. DIABETES CARE
- Notice
- (2012) Kidney International Supplements
- Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response
- (2011) Hans-Georg Eichler et al. NATURE REVIEWS DRUG DISCOVERY
- Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- What can we learn from the recent blood glucose lowering megatrials?
- (2010) Juliana CN Chan Journal of Diabetes Investigation
- Intensive glucose control and macrovascular outcomes in type 2 diabetes
- (2009) F. M. Turnbull et al. DIABETOLOGIA
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started